ISRCTN ISRCTN27990239
DOI https://doi.org/10.1186/ISRCTN27990239
Secondary identifying numbers SEPOC1
Submission date
02/09/2013
Registration date
12/09/2013
Last edited
12/09/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Cardiovascular disease (CVD) covers a number of heart and circulatory diseases including heart attack, stroke, coronary artery disease and heart failure. In the UK it is the cause of a quarter of all deaths and is thought to cost the economy around £19 billion a year. CVD has a long phase where the disease is present but the sufferer does not show symptoms. There is a need to develop a test where CVD and people at risk of developing the disease can be identified as early as possible so that they can receive the care they need. This study aims to test a new, simple, low-cost medical device which has been developed to assess a person’s risk of CVD. The device shines a light on the patient’s arm to see if the blood vessels are responding the way they should to a period of decreased blood flow or if they are showing signs of disease. The study will test how reliable this new device is and if it is able to spot patients who have CVD or who may go on to develop CVD in the future. It will also look at whether the new test is acceptable to patients by asking them for feedback about their experience.

Who can participate?
The study involves male and female participants who are 18-80 years old and attending hospital for tests relating to CVD.

What does the study involve?
Participants complete one study visit where one measurement will be taken with the new device and questions asked about the participant’s medical history, demographics and their experience of the test. Participants who agree to follow up will then be followed for 10 years by the research team who will access their medical records and record results of any tests relating to CVD.

What are the possible benefits and risks of participating?
There is no direct benefit to participants taking part in the study; however, this research may lead to the development of a new test which could help others in the future. The risks involved in taking part in the study are very small and similar to that of getting your blood pressure taken.

Where is the study run from?
The study will be run at one site in Ninewells Hospital, Dundee, Scotland (UK).

When is the study starting and how long is it expected to run for?
Recruitment will begin around March 2014 and 200 study visits will be completed over a period of 4 months. There will then be a 10 year follow up period.

Who is funding the study?
The study is funded by Northwood Trust and Scottish Enterprise, UK.

Who is the main contact?
Professor C. Jackson
cj21@st-andrews.ac.uk

Contact information

Prof Cathy Jackson
Scientific

School of Medicine
University of St Andrews
North Haugh
St Andrews
KY16 9TF
United Kingdom

Email cj21@st-andrews.ac.uk

Study information

Study designSingle site medical device feasibility study
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleAssessing the use of light as a non-invasive tool for the evaluation of individual risk of cardiovascular disease
Study objectivesIs a new test using light a reliable indicator of an individual's risk of developing cardiovascular disease?

Primary objective
To verify that the investigational device works as proposed by the manufacturer in a clinical setting.

Secondary Objectives
1. To determine the correlation between measurements made using photonics after induced ischaemia on a patients forearm and other currently used diagnostic evaluations of CVD.
2. To determine which of the above, independently, most strongly predicts exacerbation rates retrospectively (current diagnostic evaluations or photonics device).
3. To determine the acceptability of the photonic measurement as a potential screening tool for CVD.
Ethics approval(s)Ref: 13/SS/0172. The study will be reviewed by South East Scotland REC 2 on 25th September 2013.
Health condition(s) or problem(s) studiedCardiovascular disease
InterventionParticipants will undergo one test with the new device. This consists of having an inflatable blood pressure cuff placed on the upper arm and a low intensity light source shone on the lower arm. The test takes around 10mins to compete in total. Participants will then be asked questions regarding their experience of the new test.
Intervention typeOther
Primary outcome measureThe reliability of the device as measured by number of decipherable measurements produced during the study.
Secondary outcome measures1. Correlation between device measurement and current diagnostic results
2. Correlation between follow up exacerbation rate and device measurement
3. Acceptability of device measurements as described by participant feedback scores and number of adverse device effects recorded
Overall study start date01/03/2014
Completion date30/06/2024

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit80 Years
SexBoth
Target number of participants200
Key inclusion criteria1. Written informed consent given by participant.
2. Male or female patients aged 18 to 80 years inclusive.
3. Undergoing investigations for cardiovascular disease (CVD)
4. Is likely to have, or has had recent diagnostic investigations performed as part of routine clinical care relevant to diagnosis of CVD
Key exclusion criteria1. Any clinically significant medical condition or abnormality, which, in the opinion of the investigator, or cardiologist might compromise the safety of the patient
2. Females who are known to be pregnant or lactating
Date of first enrolment01/03/2014
Date of final enrolment30/06/2024

Locations

Countries of recruitment

  • Scotland
  • United Kingdom

Study participating centre

School of Medicine
St Andrews
KY16 9TF
United Kingdom

Sponsor information

University of St Andrews (UK)
University/education

Research BD and Contracts
The Gateway
North Haugh
St Andrews
KY16 9RJ
Scotland
United Kingdom

Website http://www.st-andrews.ac.uk/
ROR logo "ROR" https://ror.org/02wn5qz54

Funders

Funder type

Industry

Northwood Trust (SC013532) (UK) - ref: F611XX

No information available

Scottish Enterprise (Uk) - ref: PS7305CA20

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No